Skip to content
GERICLINICS

GeriQBank · Paper II · Q16

Ascites and refractory ascites

Not rated7-mark answer
Chapter
Part II — Hepatology
Years asked
Not recorded in the source
Frequency
No university frequency data for this paper yet

Answer framework

  1. 1. Causes and initial assessment — diagnostic paracentesis; SBP threshold
  2. 2. SAAG and grading
  3. 3. First-line management — salt, diuretic ratio, weight-loss targets, drugs to stop
  4. 4. Refractory ascites — definition and prognosis
  5. 5. Management of refractory ascites — paracentesis with albumin, TIPS criteria, beta-blocker caution, palliative drains, transplant; update — earlier TIPS (Baveno VII), long-term albumin (ANSWER)

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark answer before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • Cirrhosis with portal hypertension causes about 80% of ascites; others — peritoneal carcinomatosis, heart failure, TB, nephrotic syndrome, pancreatitis; tap every new ascites for cell count, albumin, protein, bedside blood-culture-bottle culture, cytology and ADA as indicated — neutrophils ≥250/mm³ = SBP.
  • SAAG ≥1.1 g/dL = portal hypertension (cardiac ascites has protein >2.5 g/dL, cirrhotic <2.5); SAAG <1.1 = malignancy, TB, pancreatic or nephrotic ascites; grade 1 ultrasound-only, grade 2 moderate symmetrical distension, grade 3 large or tense.
  • Salt 5–6 g (about 2 g sodium) a day; fluid restriction only if sodium below 125 mmol/L; spironolactone 100 mg with furosemide 40 mg (100:40 ratio), stepping up to 400 mg and 160 mg; target weight loss 0.5 kg/day without oedema, up to 1 kg/day with oedema; monitor weight, sodium, potassium, creatinine; stop NSAIDs, ACEi and ARBs.
  • Refractory ascites can't be mobilised or recurs early despite treatment — diuretic-resistant (no response to maximal doses) or diuretic-intractable (encephalopathy, creatinine above 2 mg/dL, sodium below 125, potassium problems); it affects about 10% with only 50% one-year survival.
  • Serial large-volume paracentesis with albumin 8 g per litre when more than 5 litres are removed; TIPS for repeated paracentesis — not with recurrent encephalopathy, age over 70, Child-Pugh >13 or cardiac dysfunction; stop beta-blockers if systolic BP falls below 90 mmHg, with hyponatraemia or AKI; tunnelled drains or alfapump for palliation; transplant referral; watch for SBP, HRS, hyponatraemia, umbilical hernia, hepatic hydrothorax.
  • Update — Baveno VII: consider covered-stent TIPS earlier, with three or more large-volume paracenteses a year, regardless of varices (better transplant-free survival); ANSWER (Lancet 2018): long-term weekly albumin improved survival in uncomplicated ascites — used in some countries, but debated and costly in India.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

Answer — Textbook Core (6 points)

1.

Causes and initial assessment. Cirrhosis with portal hypertension accounts for about 80%; other causes are malignancy (peritoneal carcinomatosis), heart failure, tuberculosis, nephrotic syndrome and pancreatitis. Perform a diagnostic paracentesis in every patient with new-onset ascites — send cell count and differential, albumin, total protein, culture inoculated into blood culture bottles at the bedside, and cytology and adenosine deaminase where indicated. Neutrophils ≥250/mm³ diagnoses spontaneous bacterial peritonitis.

2.

Serum-ascites albumin gradient (SAAG). SAAG ≥1.1 g/dL indicates portal hypertension (cirrhosis, cardiac ascites — cardiac ascites has an ascitic protein >2.5 g/dL, cirrhotic <2.5). SAAG <1.1 g/dL indicates non-portal causes — malignancy, tuberculosis, pancreatic or nephrotic ascites.

3.

Grading. Grade 1 detectable only on ultrasound; Grade 2 moderate, with symmetrical abdominal distension; Grade 3 large or tense ascites.

4.

First-line management. Sodium restriction to 5–6 g of salt (about 2 g sodium) per day; fluid restriction only if serum sodium is below 125 mmol/L. Spironolactone 100 mg with furosemide 40 mg daily, maintaining the 100:40 ratio, increased stepwise to maxima of 400 mg and 160 mg. Target weight loss of 0.5 kg/day without oedema and up to 1 kg/day with oedema. Monitor weight, sodium, potassium and creatinine, and stop NSAIDs, ACE inhibitors and ARBs.

5.

Definition of refractory ascites. Ascites that cannot be mobilised or that recurs early and cannot be prevented, and is either diuretic-resistant (no response to maximal diuretic doses with salt restriction) or diuretic-intractable (diuretic-induced complications — encephalopathy, creatinine rise above 2 mg/dL, sodium below 125 mmol/L, or potassium disturbance — preventing the use of effective doses). It occurs in about 10% and carries a 1-year survival of only 50%.

6.

Management of refractory ascites. Serial large-volume paracentesis with albumin 8 g per litre removed whenever more than 5 litres is drained (to prevent post-paracentesis circulatory dysfunction). TIPS for patients needing repeated paracenteses — contraindicated with recurrent encephalopathy, age over 70, Child-Pugh >13 or cardiac dysfunction. Discontinue beta-blockers if systolic BP falls below 90 mmHg, or with hyponatraemia or AKI. Consider indwelling tunnelled peritoneal drains or an alfapump for palliation, and refer for liver transplantation. Watch for SBP, hepatorenal syndrome, hyponatraemia, umbilical hernia and hepatic hydrothorax.

Latest Update (2023–2026) — 1 point

7.

Baveno VII plus recent trial evidence — TIPS with covered stents should now be considered earlier, in patients requiring three or more large-volume paracenteses per year, irrespective of the presence of varices or previous variceal bleeding, as this improves transplant-free survival compared with repeated paracentesis. In addition, the ANSWER trial (Lancet 2018) and subsequent data support long-term weekly albumin infusion in uncomplicated cirrhotic ascites, which improved survival and reduced complications; this is now standard in some countries, although confirmatory evidence remains debated and cost limits its use in Indian practice.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page